| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |